相似文献
1
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines.
Transl Oncol. 2021 May;14(5):101040. doi: 10.1016/j.tranon.2021.101040.
2
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines.
Transl Oncol. 2021 May;14(5):101041. doi: 10.1016/j.tranon.2021.101041.
3
Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines.
Transl Oncol. 2021 Jan;14(1):100941. doi: 10.1016/j.tranon.2020.100941. Epub 2020 Nov 19.
4
[Endogenous porcine retroviruses and xenotransplantation].
Pathol Biol (Paris). 2000 May;48(4):395-8.
5
The origin of porcine endogenous retroviruses (PERVs).
Arch Virol. 2021 Apr;166(4):1007-1013. doi: 10.1007/s00705-020-04925-8. Epub 2021 Feb 6.
6
Endogenous retrovirus sequences expressed in male mammalian reproductive tissues: a review.
East Afr Med J. 2002 Jan;79(1):38-41. doi: 10.4314/eamj.v79i1.8923.
7
Endogenous Retroviruses: What risks do they pose in xenotransplant.
Afr J Health Sci. 2001 Jan-Jun;8(1-2):24-32.
8
Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines.
Int J Oncol. 2010 Mar;36(3):545-51. doi: 10.3892/ijo_00000528.
9
Pert analysis of endogenous retroviruses induced from K-BALB mouse cells treated with 5-iododeoxyuridine: a potential strategy for detection of inducible retroviruses from vaccine cell substrates.
Dev Biol (Basel). 2001;106:387-92; discussion 392-3.
10
Structure of endogenous retroviruses expressed in radiation-induced and spontaneous murine bone tumours.
Leuk Res. 1986;10(7):923-30. doi: 10.1016/0145-2126(86)90324-3.
引用本文的文献
1
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines.
Transl Oncol. 2021 May;14(5):101041. doi: 10.1016/j.tranon.2021.101041.
本文引用的文献
1
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
Front Immunol. 2020 Nov 9;11:595035. doi: 10.3389/fimmu.2020.595035. eCollection 2020.
2
Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines.
Transl Oncol. 2021 Jan;14(1):100941. doi: 10.1016/j.tranon.2020.100941. Epub 2020 Nov 19.
3
Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy.
Int J Mol Sci. 2020 Jul 8;21(14):4843. doi: 10.3390/ijms21144843.
4
Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.
Blood Adv. 2019 Jul 9;3(13):2022-2034. doi: 10.1182/bloodadvances.2019000194.
5
Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice.
Oncotarget. 2019 Feb 15;10(14):1458-1472. doi: 10.18632/oncotarget.26680.
6
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol. 2016 Jun;17(6):822-835. doi: 10.1016/S1470-2045(16)00099-1. Epub 2016 Apr 27.
7
Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.
Clin Cancer Res. 2015 Jan 15;21(2):471-83. doi: 10.1158/1078-0432.CCR-14-0388. Epub 2014 Nov 4.
8
Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks.
Stem Cells Int. 2011;2011:795239. doi: 10.4061/2011/795239. Epub 2011 Jul 18.
9
Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.
Cancer Res. 2008 Jul 15;68(14):5869-77. doi: 10.1158/0008-5472.CAN-07-6838.
10
Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
Cancer Res. 2005 Mar 15;65(6):2207-15. doi: 10.1158/0008-5472.CAN-04-1882.
Zotero 插件